Post Authorization Safety Study (PASS) among Patients Treated with Flixabi for Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Other Spondyloarthropathies (SpA), and Psoriatic Arthritis (PsA) within the Swedish, Population based, Anti-Rheumatic Therapies in Sweden (ARTIS) register. (Safety of Flixabi in ARTIS)

ENCePP Code of conduct

No

Data sources

No information provided.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No

Procedures

No information provided.